Clinical Trials with Cannabis Extract (Cannador®) at the IKF Berlin
At the moment there are no projects with "Cannabis-Extract" in preparation or in work
C. COMPLETED PROJECTS
- Randomized, double-blind, placebo-controlled phase-III trial to compare the efficacy of standardized cannbis extract and isolated Delta-9-THC on anorexia / cachexia in cancer patients (97-20)
- Monitoring of implementation ('Anwendungsbeobachtung') of Medical Grade Marihuana (Cannabis sativa) in the Netherlands (97-22)
- Randomised, placebo controlled, double-blind, crossover pilot study to evaluate the safety and tolerability of orally administered cannabinoids in patients with Multiple Sclerosis (98-11)
- Standardized survey to the medicinal use of cannabis products in the German-speaking area (98-17)
- Open-label, non-randomized phase-II trial to determine the maximal tolerable dose (MTD) of standardized cannabis extract in the palliative treatment of cancer patients (99-09)
- Randomized, double-blind, placebo-controlled phase-II study with cross-over design to determine tolerability, optimal dose and clinical effects of standardized cannabis extract in MS-induced spasticity (99-11)
- Randomized, double-blind, placebo-controlled cross-over trial for the treatment of herpes-zoster associated pain with a standardized cannabis extract (20-07)
- Randomized, double-blind, placebo-controlled phase-II trial with cannabis extract in post-operative nausea and vomiting: PONV (21-01)
- Randomized, double-blind, placebo-controlled phase-III trial of standardized cannabis extract and Delta-9-THC in Multiple Sclerosis: CAMS (21-04)
- Phase-I-Studie zum Vergle ich von standardisiertem Cannabis-Extrakt mit THC in Hinsicht auf pharmakokinetische und kognitive/ neurophysiologische Parameter (21-06)
- Sicherheit, Verträglichkeit und Wirkung von Cannabis-Extrakt in einem Hyperalgesiemodell bei gesunden Probanden (22-01)
- Prospektive, offene, nicht-randomisierte Studie mit Cannabis-Extrakt in der adjuvanten Tumorschmerztherapie (23-09)
- Randomisierte, doppelblinde, placebokontrollierte Phase-II-Studie mit standardisiertem Cannabis-Extrakt bei Morbus Crohn (24-02)
- Randomisierte, doppelblinde, placebokontrollierte Phase-III-Studie zur Bestimmung der Wirksamkeit von standardisiertem Cannabis-Extrakt auf Spastik und Schmerzen bei Multipler Sklerose: MUSEC (25-01)
